Literature DB >> 12489920

Which Alzheimer patients are at risk for rapid cognitive decline?

Ruth O'Hara1, Jean M Thompson, Helena C Kraemer, Catherine Fenn, Joy L Taylor, Leslie Ross, Jerome A Yesavage, Amber M Bailey, Jared R Tinklenberg.   

Abstract

In the current study of 1062 Alzheimer's disease (AD) patients, we employed receiver operating characteristic curve analysis to identify characteristics of patients at increased risk for rapid cognitive decline. The patients are participants at one of the nine Alzheimer's Disease Research Centers of California. Rapid decline was defined as a 3-point or greater loss on the Mini-Mental State Examination (MMSE) per year, post visit. The independent variables were age at clinic visit, age at symptom onset of AD, MMSE at patient visit, years of education, gender, ethnicity, living arrangement, presence of aphasia, delusions, hallucinations, and extrapyramidal signs. Receiver operating characteristic curve analysis indicated that AD patients presenting with moderate to severe aphasia, age at clinic visit of 75 years or less, and an MMSE greater than 7 were at increased risk for rapid cognitive decline. This information could help clinicians target these patients for pharmacologic interventions, facilitate long-term care planning, and potentially create savings by delaying or stabilizing the course of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12489920     DOI: 10.1177/089198870201500409

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  18 in total

1.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Authors:  Nathan Herrmann; Tetsuhiro Harimoto; Robert Balshaw; Krista L Lanctôt
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

3.  Donepezil treatment in ethnically diverse patients with Alzheimer disease.

Authors:  Jared R Tinklenberg; Helena C Kraemer; Kristine Yaffe; Ruth O'Hara; John M Ringman; John W Ashford; Jerome A Yesavage; Joy L Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2014-09-28       Impact factor: 4.105

4.  Rapid cognitive decline, one-year institutional admission and one-year mortality: analysis of the ability to predict and inter-tool agreement of four validated clinical frailty indexes in the SAFEs cohort.

Authors:  M Dramé; J-L Novella; D Jolly; I Lanièce; D Somme; D Heitz; J-B Gauvain; T Voisin; B De Wazières; R Gonthier; C Jeandel; P Couturier; O Saint-Jean; J Ankri; F Blanchard; P-O Lang
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

5.  Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.

Authors:  Mili Parikh; Linda S Hynan; Myron F Weiner; Laura Lacritz; Wendy Ringe; C Munro Cullum
Journal:  Clin Neuropsychol       Date:  2014-08-18       Impact factor: 3.535

6.  Does cognition predict treatment response and remission in psychotherapy for late-life depression?

Authors:  Sherry A Beaudreau; Tiffany Rideaux; Ruth O'Hara; Patricia Arean
Journal:  Am J Geriatr Psychiatry       Date:  2014-09-21       Impact factor: 4.105

7.  Motor signs predict poor outcomes in Alzheimer disease.

Authors:  N Scarmeas; M Albert; J Brandt; D Blacker; G Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; D Wegesin; K Marder; K Bell; L Honig; Y Stern
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

8.  Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.

Authors:  L Carcaillon; G Berrut; F Sellal; J F Dartigues; S Gillette; J J Pere; I Bourdeix
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

9.  Association between cerebral shape and social use of language in Williams syndrome.

Authors:  Doron Gothelf; Yvonne M Searcy; Judy Reilly; Philip T Lai; Tope Lanre-Amos; Debra Mills; Julie R Korenberg; Albert Galaburda; Ursula Bellugi; Allan L Reiss
Journal:  Am J Med Genet A       Date:  2008-11-01       Impact factor: 2.802

10.  Who is at risk for dropout from group cognitive-behavior therapy for insomnia?

Authors:  Jason C Ong; Tracy F Kuo; Rachel Manber
Journal:  J Psychosom Res       Date:  2008-04       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.